Riggleman v. Smith

CourtDistrict Court, W.D. Virginia
DecidedSeptember 3, 2024
Docket7:22-cv-00018
StatusUnknown

This text of Riggleman v. Smith (Riggleman v. Smith) is published on Counsel Stack Legal Research, covering District Court, W.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Riggleman v. Smith, (W.D. Va. 2024).

Opinion

CLERK'S OFFICE U.S. DIST. COURT AT ROANOKE, VA FILED IN THE UNITED STATES DISTRICT COURT 9/3/2024 FOR THE WESTERN DISTRICT OF VIRGINIA — LAURA A. AUSTIN, CLERK ROANOKE DIVISION BY: Beeson DEPUTY CLERK TERRY A. RIGGLEMAN, ) ) Plaintiff, ) Civil Action No. 7:22cv00018 ) ) MEMORANDUM OPINION V. ) ) By: Norman K. Moon KYLE SMITH, M.D., ) United States District Judge ) Defendant. ) ) The sole remaining defendant in this pro se prisoner action, Kyle Smith, M.D., moves for summary judgment on plaintiff Terry Riggleman’s claim that Dr. Smith was deliberately indifferent in his treatment of plaintiff's Hepatitis C infection. Compl., Dkt. 1. Dr. Smith’s motion will be granted, and the Court will award Dr. Smith summary judgment. Dkt. 59. I. BACKGROUND A. Plaintiff's Allegations The facts giving rise to this litigation took place when Plaintiff was incarcerated at the Augusta Correctional Center (ACC). Plaintiff alleges that in May 2018, physicians at the University of Virginia recommended treatment for Hepatitis C and Dr. Smith ignored the recommendation. Compl. at 7. Plaintiff concedes that Dr. Smith signed off on certain diagnostic studies but claims that he would not allow UVA hospital to treat his Hepatitis C. /d. at 20. Plaintiff then claims that from June 2018 until January 2020, Dr. Smith was his primary care physician, and during that time, his Hepatitis C went untreated. /d. Plaintiff claims that the untreated Hepatitis C caused significant physical injury, substantial risk of harm, and that his condition significantly deteriorated. /d.

B. Previous Motions to Dismiss On March 14, 2023, the Court issued an opinion and order granting a motion to dismiss filed by defendants Harold Clarke, at the time the Director of the Virginia Department of Corrections (VDOC), and Dr. Mark Amonette, VDOC’s Chief Medical Director. Dkt. 47. In the same order, the Court denied a motion to dismiss filed by Dr. Smith. The Court granted the motion filed by Clarke and Dr. Amonette because plaintiff raised the same claims against them in a separate lawsuit, Riggleman v. Clarke, No. 5:17-cv-00063 (“Riggleman I’). Thus, the claims against Clarke and Dr. Amonette constituted improper claim splitting. Dkt. 47 at 10. The Court denied Dr. Smith’s motion because he was not a party to Riggleman I, and based on the limited record before it, the Court concluded that Dr. Smith was not in privity with the Riggleman I defendants. /d. at 10-16. C. Plaintiff's Medical Treatment In support of his motion for summary judgment, Dr. Smith has provided a declaration and relevant medical records from ACC. See Exs. A, B, Dkts. 60-1, 60-2, 60-3. Dr. Smith is a Board-certified physician licensed to practice medicine in the Commonwealth of Virginia. He completed his residency training in 2015 and has practiced primary care medicine since that time. Dr. Smith provides primary care services to inmates at ACC and is currently its Medical Director. Beginning in June 2018, Dr. Smith has been employed by companies contracted with the VDOC to provide healthcare to inmates housed in the ACC and other prisons in the Commonwealth of Virginia. Dr. Smith did not begin to manage plaintiffs Hepatitis C until August 2019. Prior to that time, the chronic care physician was Dr. Ricardo Martinez. Ex. A, § 10. Based on diagnostic

' Dr. Smith also submitted a document under seal relevant to the privity issue. Ex. C, Dkt. 59-1.

studies, treatment for Hepatitis C was not indicated prior to September 2019 when a change was noted in Riggleman’s Fibroscan. /d.; Ex. B, SA 0439-0444. Once Dr. Smith took over plaintiff's care and there was a change in condition, Dr. Smith obtained treatment for plaintiff, consulted with outside specialists, reviewed studies and labs, and ordered ongoing treatment modalities in accordance with the recommendations of the specialists in addition to utilizing his education, training, and experience to make determinations about on-site monitoring. Ex. A, ¥ 10. According to the medical records, prior to Dr. Smith’s arrival at ACC, a Utilization Management Request was placed for a Fibroscan to be done at the UVA digestive health clinic on May 16, 2018. Ex. A, § 11; Ex. B, SA 0504. At that time, plaintiff was noted to be a 42-year- old male who had been positive for Hepatitis C genotype 1b since 2005. The request was approved. /d. Following the Fibroscan, plaintiff was seen by Dr. Martinez on June 18, 2018, who documented that plaintiff did not qualify for treatment at that time per DOC policy. Ex. A, § 12; Ex. B, SA 0560. Plaintiff was seen for a follow-up regarding his Hepatitis C in the Chronic Care Clinic by Dr. Martinez on September 28, 2018. Dr. Martinez documented: “No chest pain. No SOB. No palpitations. No ankle edema. No nausea/vomiting. No abdominal pain/swelling. No diarrhea. No rashes/lesions.” He also noted no new symptoms for diseases. The physical exam was documented as normal. Lab results for the liver function were still pending. Ex. A, § 13; Ex. B, 0551. Dr. Martinez reviewed the lab results on October 26, 2018, and found that plaintiff did not qualify for treatment for Hepatitis C according to DOC protocol. Ex. A, § 14; Ex. B, SA 0550. The results revealed an Apri Score of 0.534, which is consistent with low risk for cirrhosis. Id. Plaintiff also had a Fib 4 score of 1.10; a value below 1.30 is considered low risk for

advanced fibrosis, or tissue injury in the liver. Ex. A, J 14. On January 19, 2019, a Fibroscan was completed at UVA, and the report was sent to Dr. Mark Amonette, VDOC’s Chief Medical Director. /d. Dr. Martinez saw plainitff in the Chronic Care Clinic regarding his Hepatitis C on March 27, 2019. Ex. A, J 16; Ex. B, SA 0544. Dr. Martinez noted that plaintiff's Hepatitis C was being monitored with Fibroscan, Apri Score, and Fib-4. Plaintiff reported no new symptoms at that visit. Dr. Martinez ordered a complete metabolic panel and other lab studies at that visit, with a return follow up in 180 days. /d. Although Dr. Smith was not following plaintiff for his Hepatitis C at that time, he did review the lab results as was his custom and practice if lab studies came across his desk. Ex. A, J 17. On April 1, 2019, Dr. Smith reviewed plaintiff's liver function studies and found that they were in an acceptable range for his condition. Ex. B, SA 0733-0734. The first time Dr. Smith became plaintiff's main physician overseeing his Hepatitis C care was on August 19, 2019. At that time, Dr. Smith wrote that plaintiff was to be “prioritized” for a Fibroscan. Ex. A, § 18; Ex. B, 0537. On September 18, an order was placed to perform the test on site, and it was completed two days later. Ex. A, § 19; Ex. B, SA 0464, 0530. Dr. Smith also ordered an ultrasound of plaintiff's abdomen, which was performed onsite on October 2. Ex. A, § 20; Ex. B, 0731. There were no abnormal findings on the ultrasound. Ex. A, 4 21; Ex. B, 0731. However, due to the results of the Fibroscan, which had changed in comparison to the prior study, Dr. Smith referred plaintiff to VCU for treatment. Ex. A, § 21; Ex. B, SA 532, 726. Plaintiff consented to participate in telemedicine with the VCU hepatology clinic on November 6, 2019. Ex. A, § 22; Ex. B, SA 0439-45. The VCU clinician noted that plaintiff

had been diagnosed with Hepatitis C in 2005. His risk factors included intravenous drug use and prison tattoos. She stated: “Although prior FibroScan study which was done at UVA in 2018 showed no significant fibrosis at all, most recent FibroScan study which was done on 09/26/2019 showed fibrosis median score 13.1 kPa, suggesting advanced fibrosis or cirrhosis.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Haines v. Kerner
404 U.S. 519 (Supreme Court, 1972)
Cruz v. Beto
405 U.S. 319 (Supreme Court, 1972)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Wilson v. Seiter
501 U.S. 294 (Supreme Court, 1991)
Iko v. Shreve
535 F.3d 225 (Fourth Circuit, 2008)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Samuel Jackson v. Joseph Lightsey
775 F.3d 170 (Fourth Circuit, 2014)
Paul Scinto, Sr. v. Warden Stansberry
841 F.3d 219 (Fourth Circuit, 2016)
Paul Thompson, Jr. v. Commonwealth of Virginia
878 F.3d 89 (Fourth Circuit, 2017)
Carter v. Morris
164 F.3d 215 (Fourth Circuit, 1999)
Grayson v. Peed
195 F.3d 692 (Fourth Circuit, 1999)
Beale v. Hardy
769 F.2d 213 (Fourth Circuit, 1985)

Cite This Page — Counsel Stack

Bluebook (online)
Riggleman v. Smith, Counsel Stack Legal Research, https://law.counselstack.com/opinion/riggleman-v-smith-vawd-2024.